Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.20
Bid: 21.20
Ask: 21.55
Change: 0.00 (0.00%)
Spread: 0.35 (1.651%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 21.20
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Zircadian

12 Aug 2011 07:00

RNS Number : 2455M
Allocate Software PLC
12 August 2011
 



 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

Acquisition of Zircadian

 

Allocate Software, (AIM:ALL), the leading provider of workforce and compliance optimisation solutions has acquired Zircadian Holdings Limited ("Zircadian" or the "Company"), the UK based SaaS provider of software used to plan the rotas of junior doctors and consultants in the NHS, for a total consideration of up to £7.0 million. The total consideration includes a deferred payment of £1.0 million contingent on financial targets and £0.5 million contingent on key staff retentions. Zircadian had net cash of approximately £1.0 million at 31 July 2011.

 

Overview of Zircadian and the Acquisition

§ Zircadian is a leading UK supplier of software to plan the rotas of junior doctors and consultants in the 

NHS. The business uses a SaaS delivery model and most contracts are multiple year agreements

§ Its products are used by 142 healthcare organisations in the UK

§ Functionality is complementary to Allocate's existing nurse rostering software, HealthRoster

§ In the year ended 31 March 2011, unaudited management accounts reported c.£3.0m in billings, c.£2.5

million in recognised revenues and approximately £0.2 million in EBITDA.

§ Zircadian employs 43 staff who are based in Wimbledon, London

§ The total consideration of £7.0 million is structured as an initial payment of £5.5 million and two further

payments totalling £1.5 million, subject to certain conditions (described below)

§ The acquisition is expected by the Directors to be earnings enhancing in the first full financial year of

ownership by Allocate

 

Ian Bowles, CEO of Allocate commented: "We are delighted to conclude our sixth acquisition, one which complements our HealthRoster application well, thereby significantly enhancing the product portfolio and value that we can bring to our customer base both within the NHS and elsewhere. The alignment of Zircadian's products with Allocate's reinforces the benefits of our focused M&A strategy in which we aim to continue to build a significant healthcare applications company. I welcome the Zircadian team to Allocate and look forward to further building on our existing relationships within our mutual customer base."

 

Commenting on the acquisition, Dr Henry Carleton, Director of Zircadian said: "I am proud of what the team at Zircadian has achieved in developing and growing the business over the past eleven year and we are delighted to join forces with Allocate, the market leader in its field. The integration of our application into the broader HealthRoster application Suite is a natural step, and one which provides the combined groups customers with a highly complementary product offering."

 

Zircadian

Zircadian was founded in 2000 by Dr Henry Carleton and Dr Angus MacDougall and since then has expanded and diversified to become the leading SaaS provider of software to plan the rotas and job plans of junior doctors and consultants respectively in the NHS.

 

These solutions are delivered principally through two applications:

§ Junior Doctor Portal - rota management software "e-Rota", online diary management systems "e-Monitor" 

and "e-Locum" for managing temporary (locum) staff; and

§ Consultant Portal - job planning "e-JobPlan", annual leave "e-Leave" and appraisal management "e-

Appraisal".

 

Consideration

The total consideration of £7.0 million is structured as an initial payment of £5.5 million and two further payments totalling £1.5 million:

§ £0.5 million payable based upon the Directors remaining with Allocate for a period of at least six months

from completion; and

§ £1.0 million payable upon the achievement of certain future financial targets.

 

The purchase will be funded from existing cash resources and debt. The debt will take the form of an increase in the company's existing revolving credit facility by an amount of £2.0 million. The balance of the initial payment of approximately £3.5 million will be funded from existing cash resources while any future payments will be funded from cash generated by the enlarged group.

 

Customer Base and Technology

As at 31 July 2011, Zircadian had 142 healthcare customers in the UK, comprising 107 NHS Trusts using the Junior Doctor Portal and 68 using Consultant Portal.

 

Zircadian's technology has been built using a Microsoft .NET platform and Microsoft SQL Server database - consistent with Allocate's own technology. Zircadian's products are deployed in a fully multi-tenant, hosted SaaS environment.

 

Management of Zircadian

Dr Henry Carleton and Dr Angus MacDougall, the two founders of Zircadian, will join the senior management team of Allocate. 

 

Acquisition Rationale

The acquisition of Zircadian is consistent with the strategy set by Allocate to expand its breadth of healthcare applications with a focus on helping customers to drive operational efficiencies and deliver cost savings.

 

The acquisition is expected by the Directors to be earnings enhancing in the first full financial year of ownership by Allocate. Furthermore, the Board believes that the subscription nature of Zircadian's business model, with high levels of recurring revenue, will enhance revenue visibility.

 

The Board believes that there continues to be significant potential for organic growth within the UK healthcare market which will be enhanced by this acquisition and the opportunity to generate incremental revenues from cross-selling, building on the existing customer base of both businesses despite the recent Government changes to the NHS.

 

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Strata Partners (Financial Adviser)

Edward Roskill

Alistair Armstrong-Brown

 

Tel: +44 (0) 20 7730 1200

Numis Securities Limited (NOMAD / Corporate Broker)

Nominated adviser - Michael Meade / Richard Thomas

Corporate Broking - James Black

 

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

John Bick

 

Tel: +44 (0) 20 7193 7463

+44 (0) 7525 324 431

 

 

 

About Allocate Software plc

Allocate Software plc is the leading workforce and compliance optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence. At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUAABRAAAWAAR
Date   Source Headline
2nd May 20247:00 amRNSApproval to List on the Ghana Stock Exchange
24th Apr 20247:00 amRNSQuarterly Activities and Cash Flow Report
18th Apr 20247:00 amRNSExploration-focused Investor Webinar
16th Apr 20247:00 amRNSInvestor Presentation - Paydirt Battery Minerals
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFurther Broad and High-Grade Drill Intersections
15th Mar 20247:00 amRNSHalf-year Financial Report
27th Feb 20247:00 amRNSConference Attendance
15th Feb 20247:00 amRNSDirector/PDMR Dealings
5th Feb 20247:00 amRNSMultiple Broad and High-Grade Drill Intersections
2nd Feb 20247:00 amRNSConference Attendance – Mining Indaba
1st Feb 20248:20 amRNSInvestor Presentation - Investor Webinar
31st Jan 20247:00 amRNSQuarterly Activities and Cash Flow Report
29th Jan 20247:00 amRNSInvestor Webinar
25th Jan 20247:00 amRNSUpdate on Competitive Offtake Partnering Process
24th Jan 20247:00 amRNSCompletion of US$5m MIIF Subscription
23rd Jan 20247:00 amRNSTR-1 Notification of Major Holdings
2nd Jan 20247:00 amRNSCorporate Update - Director / PDMR Shareholding
29th Dec 20237:00 amRNSCorporate Update - Director / PDMR Shareholding
28th Dec 20237:00 amRNSGrant of PDMR Performance Rights
22nd Dec 20237:00 amRNSDirector / PDMR Dealings & Shareholding Update
21st Dec 20237:00 amRNSCorporate Update - Director / PDMR Dealings
20th Dec 20237:00 amRNSBoard Changes
15th Dec 20237:00 amRNSSuccessful Completion of A$8million Equity Placing
14th Dec 20234:45 pmRNSA$7 million Equity Placing
12th Dec 20237:00 amRNSMaiden Feldspar Mineral Resource Estimate
30th Nov 202311:57 amRNSAmended Constitution
30th Nov 202311:50 amRNSResult of Annual General Meeting
30th Nov 20237:02 amRNSAGM Statement
28th Nov 20237:00 amRNS106m Continuous Pegmatite Interval Reported
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.